Skip to main content

Physical samples for batch release not required: a reminder for sponsors of biosimilars and biological medicines

A change in process has been implemented to facilitate batch release of biological medicines during the COVID-19 pandemic
Last updated

Help us improve the Therapeutic Goods Administration site